AbstractBackgroundHbA1c is recommended for monitoring glycaemic control in people with cystic fibrosis-related diabetes (CFRD). However the relationship between HbA1c and mean plasma glucose concentration (MPG) has not been established in CFRD, as in other forms of diabetes mellitus.Methods20 people (13 male, 29.7±8.8 years, 10 CFRD) with cystic fibrosis (CF) underwent HbA1c measurement and 48 h continuous glucose monitoring for estimation of MPG. The relationship between HbA1c and MPG was established and compared to the reported relationship for type 1 diabetes.ResultsHbA1c was strongly correlated with MPG (R2=0.888, p<0.0001) in CF. The relationship of MPG to HbA1c was described by the equation MPG=(1.47×HbA1c)−1.15, giving a 1.47 mmol L−...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
AbstractBackgroundPulmonary decline accelerates in cystic fibrosis-related diabetes (CFRD) proportio...
AbstractBackgroundHbA1c is recommended for monitoring glycaemic control in people with cystic fibros...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Context: The clinical utility and implications of continuous glucose monitoring (CGM) in cystic fibr...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
BACKGROUND: Cystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic...
AbstractBackgroundAbnormal glucose tolerance is a frequent co-morbidity in cystic fibrosis patients ...
BackgroundCystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic d...
AbstractThe prevalence of cystic fibrosis-related diabetes (CFRD) and glucose intolerance (IGT) has ...
OBJECTIVE Diabetes is common in cystic fibrosis and increases the risk of death, yet the role of hyp...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
AbstractBackgroundPulmonary decline accelerates in cystic fibrosis-related diabetes (CFRD) proportio...
AbstractBackgroundHbA1c is recommended for monitoring glycaemic control in people with cystic fibros...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Context: The clinical utility and implications of continuous glucose monitoring (CGM) in cystic fibr...
Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related di...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
BACKGROUND: Cystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic...
AbstractBackgroundAbnormal glucose tolerance is a frequent co-morbidity in cystic fibrosis patients ...
BackgroundCystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic d...
AbstractThe prevalence of cystic fibrosis-related diabetes (CFRD) and glucose intolerance (IGT) has ...
OBJECTIVE Diabetes is common in cystic fibrosis and increases the risk of death, yet the role of hyp...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated wi...
AbstractBackgroundPulmonary decline accelerates in cystic fibrosis-related diabetes (CFRD) proportio...